Antiphospholipid antibodies in sickle cell disease
โ Scribed by O. Kucuk; A. Gilman-Sachs; K. Beaman; L. J. Lis; M. P. Westerman
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 305 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
โฆ Synopsis
Antiphospholipid antibody formation can be Induced In mice by phospholipid In a hexagonal II phase but not by phospholipid in a bllayer phase. Since sickle red cell membranes have increased hexagonal I1 phase content, we have measured serum antiphospholipid antibody levels in 25 patients with sickle cell disease to determine whether anti-phospholipid antibody may similarly be Induced in these patients. Seventeen of the 25 patients (68%) had Increased levels of antiphospholipid antibodies. Eleven patients (65%) had IgG and six each (35%) had IgM and IgA isotypes. Antiphosphatidylethanolamine, antiphosphatidylserine, antiphosphatidyllnositol, and antlphosphatidic acid were the most frequently increased antibodies. The finding of increased antiphospholipid antibodies In these patients is compatible with the concept that antiphospholipid antibody formation is associated with structural changes in the red cell membrane and that such structural changes occur in the red cells of patients with sickle ceii disease.
๐ SIMILAR VOLUMES
Objective: Autoimmune thyroid disease (ATD) is associated with circulating autoantibodies reactive with epitopes on thyroid tissue and that are thought to be pathogenic in the development of these diseases. Antiphospholipid antibodies (APLA) are a family of immunoglobulins that recognize a variety o
Sickle cell anemia and the related hemoglobinopathies are associated with a large spectrum of renal abnormalities. The patients have impaired urinary concentrating ability, defects in urinary acidification and potassium excretion, and supranormal proximal tubular function. The latter is manifest by
Sickle cell disease is the most common inherited disorder in African-Americans. Although the primary defect is hematological, the changes in the erythrocytes lead to a vasculopathy with multiorgan injury. The pulmonary complications, i.e., acute chest syndrome and chronic sickle cell lung disease, a